Jian-da Y. Hu

Fujian Provincial Key Laboratory Of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road
Fuzhou, 350001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 94 publications

Correction: CircEAF2 counteracts Epstein-Barr viruspositive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.

Correction: CircEAF2 counteracts Epstein-Barr viruspositive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.

Journal: Molecular cancer

Published: February 20, 2026

Advancements of artificial intelligence in dry eye

Advancements of artificial intelligence in dry eye

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: February 12, 2025

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

Extranodal diffuse large B-cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study.

Journal: Cancer communications (London, England)

Published: August 13, 2024

Correlation of miR-155 Expression with Drug Sensitivity of FLT3-ITD+ Acute Myeloid Leukemia Cell Line and Its Mechanism

Correlation of miR-155 Expression with Drug Sensitivity of FLT3-ITD+ Acute Myeloid Leukemia Cell Line and Its Mechanism

Journal: Zhongguo shi yan xue ye xue za zhi

Published: April 25, 2024

The effect of unexpected follicular development in artificial cycles on the clinical outcomes in frozen thawed embryo transfer based on propensity score matching

The effect of unexpected follicular development in artificial cycles on the clinical outcomes in frozen thawed embryo transfer based on propensity score matching

Journal: Zhonghua yi xue za zhi

Published: September 07, 2023

Effect of preimplantation genetic testing for aneuploidies on pregnancy outcome in patients with unexplained recurrent spontaneous abortion

Effect of preimplantation genetic testing for aneuploidies on pregnancy outcome in patients with unexplained recurrent spontaneous abortion

Journal: Zhonghua yi xue za zhi

Published: August 14, 2023

Effect of Nucleolin on Lymphoma Proliferation by Regulating Thymidine Kinase 1

Effect of Nucleolin on Lymphoma Proliferation by Regulating Thymidine Kinase 1

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 25, 2023

A Retrospective Study on the Efficacy and Safety of Idarubicin Combined with High-Dose Cytarabine Consolidation in Patients with Acute Myeloid Leukemia over 60 Years of Age in First Remission

A Retrospective Study on the Efficacy and Safety of Idarubicin Combined with High-Dose Cytarabine Consolidation in Patients with Acute Myeloid Leukemia over 60 Years of Age in First Remission

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 25, 2023

Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.

Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.

Journal: American journal of hematology

Published: March 13, 2023

Effect of closed extension tube on preventing airway leakage during artificial airway clearance

Effect of closed extension tube on preventing airway leakage during artificial airway clearance

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: November 07, 2022

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.

Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study.

Journal: Blood advances

Published: October 27, 2022

Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study.

Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study.

Journal: EClinicalMedicine

Published: July 13, 2022

Showing 1-12 of 94

Last Updated: 09/26/2026